Literature DB >> 8275418

Partial nephrectomy for renal cell carcinoma with a normal opposite kidney.

H W Herr1.   

Abstract

BACKGROUND: The role of nephron-sparing surgery in patients with unilateral renal carcinoma and a normal opposite kidney is controversial.
METHODS: The number and selection criteria of patients undergoing a partial nephrectomy versus radical nephrectomy from 1979 to 1991 were compared.
RESULTS: Of 230 patients having curative surgery for unilateral renal cell carcinoma, 41 had a partial nephrectomy. The percentage of partial compared with total nephrectomies performed increased from 8% in 1979-84, to 20% in 1984-88, and 30% in 1989-91. The increased number of partial versus radical nephrectomies performed reflected an increased detection of small (3.5 cm) incidental renal tumors by radiologic imaging. The local recurrence rate was 2.4% (one patient), and the survival rate was 95% (average, 3 years).
CONCLUSION: Complete local excision of the small serendipitous renal tumor is feasible and reasonable in the patient with an otherwise normal opposite kidney.

Entities:  

Mesh:

Year:  1994        PMID: 8275418     DOI: 10.1002/1097-0142(19940101)73:1<160::aid-cncr2820730127>3.0.co;2-s

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  3 in total

1.  Nephron-sparing procedures in 11 patients with Wilms' tumor.

Authors:  K Linni; C Urban; H Lackner; M E Höllwarth
Journal:  Pediatr Surg Int       Date:  2003-05-17       Impact factor: 1.827

2.  Laparoscopic and percutaneous ablative techniques in the treatment of renal cell carcinoma.

Authors:  Kent Perry; Amnon Zisman; Allan J Pantuck; Nicolette Janzen; Peter Schulam; Arie S Belldegrun
Journal:  Rev Urol       Date:  2002

Review 3.  Minimally invasive ablative approaches in the treatment of renal cell carcinoma.

Authors:  Nicolette Janzen; Amnon Zisman; Allan J Pantuck; Kent Perry; Peter Schulam; Arie S Belldegrun
Journal:  Curr Urol Rep       Date:  2002-02       Impact factor: 2.862

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.